Percheron Therapeutics Ltd (ASX:PER – Get Free Report) insider Charmaine Gittleson bought 1,666,666 shares of the stock in a transaction dated Tuesday, December 31st. The shares were bought at an average price of A$0.01 ($0.01) per share, for a total transaction of A$14,999.99 ($9,316.77).
Percheron Therapeutics Stock Performance
About Percheron Therapeutics
Pernod Ricard SA produces and sells wines and spirits worldwide. It offers its products under various brands. The company was founded in 1805 and is headquartered in Paris, France.
See Also
- Five stocks we like better than Percheron Therapeutics
- Retail Stocks Investing, Explained
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- Expert Stock Trading Psychology Tips
- Nebius Group: The Rising Star in AI Infrastructure
- What is the Dogs of the Dow Strategy? Overview and Examples
- MarketBeat Week in Review – 12/30 – 1/03
Receive News & Ratings for Percheron Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Percheron Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
